Subgen AI AB Stock Price

OM:SUBGEN Community·SEK 5.2m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

SUBGEN Share Price Performance

SEK 0

-90.90 (-100.00%)

SEK 0

-90.90 (-100.00%)

SEK 0

Fri, 19 Dec 25

Share Pricen/a

SUBGEN Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Moderate risk with imperfect balance sheet.

5 Risks

0 Rewards

View Full Analysis

Subgen AI AB Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -24.23
: 0%
: 0%
: -71.5%

View Full Analysis

About SUBGEN

Founded: 2019
Employees: 15
CEO: Lorenzo Serratosa Gallardo
WebsiteView website: subgen.ai

Subgen AI AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs. The company develops a testing platform for oral health, therapeutic drug monitoring, and infectious diseases. It develops Veritope technology used to optimize the dosage of biological drugs to patients; and the MagniaReader platform. The company was formerly known as Magnasense AB and changed its name to Subgen AI AB in November 2025. Subgen AI AB was incorporated in 2019 and is based in Lund, Sweden.